期刊文献+

阿尔茨海默病患者血脂、纤维蛋白原、同型半胱氨酸水平的变化

下载PDF
导出
摘要 阿尔茨海默病(Alzheimer’s disease,AD)是一种病因尚不明确的进行性变性疾病,是老年期痴呆最常见的类型。AD准确的发病机制尚不清楚,过去一直认为AD是单纯的神经变性疾病,近几年国内外的大量研究表明,血脂代谢、血管性因素在AD的发病过程起到了重要的作用。基于此,本实验研究AD患者的血脂、纤维蛋白原、同型半胱氨酸水平的变化,探讨它们在AD发病中的变化规律,为临床上早期诊断、药物疗效观察提供有用的指标。
作者 钱辉 张宝荣
出处 《浙江医学》 CAS 2010年第11期1701-1702,共2页 Zhejiang Medical Journal
  • 引文网络
  • 相关文献

参考文献8

二级参考文献43

  • 1谭来勋,孙圣刚.胆固醇与脑和突触可塑性关系的研究进展[J].卒中与神经疾病,2006,13(6):383-383. 被引量:6
  • 2陈大伟,陈彪,杨静芳,冯秀丽,汤哲,董秀敏.胆固醇酯转运蛋白基因多态性与阿尔茨海默病的关系[J].中华神经科杂志,2006,39(12):814-817. 被引量:8
  • 3Kivipdto M, Helkala EL, Laakso MP, et al. Midlife vascular risk factors and Alzbeimer's disease in later life: longitudinal, population based study. BMJ, 2001, 322: 1447-1451.
  • 4Wolozin B, Kellman W, Ruosseau P, et al. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch Neurol, 2000, 57: 1439-1443.
  • 5Haass C, Selkoe DJ. Cellular processing of β-amyloid precursor protein and the genesis of amyloid β-peptide. Cell, 1993, 75 : 1039- 1042.
  • 6Helmuth L. New therapies. New Alzheimer's treatments that may case the mind. Science, 2002, 297:1260-1262.
  • 7Fassbender K, Simons M, Bergamann C, et al. Simvastain strongly reduces levels of Alzheimer's disease beta-amyloid peptides Abeta42 and Abeta40 in vitro and in vivo. Proc Natl Acad Sci USA, 2001, 98:5856-5861.
  • 8Abad-Rodriguez J, Ledesma MD, Craessaerts K, et al. Neuronal membrane cholesterol loss enhances amyloid peptide generation. J Cell Biol, 2004, 167: 953-960.
  • 9Stein TD, A nders N J, Decarli C, et al. Neutralization of transthyretin reverses the neuroprotective effects of secreted amyloid precursor protein (APP) in APPsw mice resulting in tan phosphorylation and loss of hippecampal neurons: support for the amyloid hypothesis. J Neurosci, 2004, 24: 7707-7717.
  • 10Ehehalt R, Keller P, Haass C, et al. Amyloidgenie processing of the Alzheimer beta amyloid precursor protein depends on lipid rafts. J Cell Biol, 2003, 160: 113-123.

共引文献6

;
使用帮助 返回顶部